FOR LABORATORY RESEARCH USE ONLY | NOT FOR HUMAN OR VETERINARY USE | NOT FOR DIAGNOSTIC OR THERAPEUTIC USE
Technical Guide

HPLC vs. LC-MS for Peptide Identity and Purity

Updated: August 19, 2026 · For laboratory, academic, and procurement evaluators

Peptide reference material Certificates of Analysis almost always report two different analytical results: an HPLC purity figure and a mass spectrometry identity confirmation. They are frequently confused as interchangeable or redundant. They are not — each answers a different question, and a supplier that only runs one of them is only telling you half the story.

What reversed-phase HPLC measures

Reversed-phase high-performance liquid chromatography (RP-HPLC) separates the components of a sample based on how they interact with a stationary phase as they are carried through a column by a solvent gradient. For a peptide, this produces a chromatogram showing a main peak (the target peptide) plus any smaller peaks representing impurities, truncated sequences, or degradation products. Purity is reported as the percentage of total peak area attributable to the main peak. HPLC is very good at telling you how much of the sample is the intended compound relative to everything else in the vial. It does not, on its own, confirm what the main peak actually is.

What LC-MS (and standalone mass spectrometry) measures

Liquid chromatography-mass spectrometry (LC-MS) pairs the same kind of chromatographic separation with a mass spectrometer detector, which measures the mass-to-charge ratio of the separated components. For a peptide, this produces an observed molecular weight that can be compared against the theoretical molecular weight calculated from its amino acid sequence. A match confirms identity — that the main peak is, in fact, the peptide it is labeled as, not a different compound that happens to elute at a similar time or share a similar purity profile.

Why both are typically used together

HPLC purity and mass spec identity answer different questions, so a complete Certificate of Analysis reports both:

MethodQuestion it answersWhat it cannot tell you
RP-HPLCHow pure is the sample? What percentage is the main component?Whether the main component is actually the labeled peptide
Mass spectrometry / LC-MSIs the main component's molecular weight consistent with the labeled peptide?How pure the sample is relative to trace impurities

A high HPLC purity result paired with no mass spec confirmation leaves open the possibility that the "pure" main peak is a different, mislabeled, or structurally similar compound. A mass spec identity match with no purity figure leaves open the question of how much non-target material is actually in the vial. Together, they support both parts of a Certificate of Analysis claim: this is the right compound, and it is present at a stated purity level.

Reading these results on a Certificate of Analysis

A CoA reporting both methods should show the HPLC purity percentage, the chromatographic method and column conditions (or a reference to them), the observed vs. theoretical molecular weight from the mass spec result, and the lot or report number both results are tied to. See our own CoA guide for a walkthrough of a full report, our HPLC purity testing and mass spectrometry identity pages for method-level detail, and quality control for how these fit into a broader analytical panel alongside heavy metals screening and water content.

Applying this when evaluating a supplier

When comparing suppliers, check whether both figures are reported per lot, not just once for the compound in general, and whether the identity result is a genuine mass spec confirmation rather than a restated theoretical molecular weight. See our broader guide to evaluating any peptide reference material supplier for the full checklist.

For laboratory research use only. Materials described on this site are chemical reagents supplied exclusively for in-vitro laboratory research by qualified persons. They are not drugs, dietary supplements, foods, cosmetics, or medical devices, are not for human or veterinary use, and are not intended to diagnose, treat, cure, or prevent any disease. See our full Research Use Policy for the terms governing purchases from BNM Research Peptides.